2026 Nader Rifai: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Best Scientists	166	988	908	587	528	595	164849
Medicine	167	577	527	336	302	593	166551

Research.com Recognitions

2025 - Research.com Best Scientists Award

Overview

Nader Rifai is a researcher affiliated with Boston Children's Hospital in the United States, with a focus in the field of Medicine. Their work spans several subfields including Surgery, Endocrinology, Diabetes and Metabolism, Epidemiology, General Health Professions, and Immunology.

Their research concentrates on multiple main topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Adipokines, Inflammation, and Metabolic Diseases, Artificial Intelligence in Healthcare and Education, Tryptophan and Brain Disorders, Health Sciences Research and Education, and Healthcare Cost, Quality, and Practices.

Among their recent publications are:

Developing a reporting guideline for artificial intelligence-centred diagnostic test accuracy studies: the STARD-AI protocol, 2021, BMJ Open
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM, 2020, Atherosclerosis
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women, 2024, New England Journal of Medicine
Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial, 2020, European Heart Journal
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy, 2022, Circulation

Frequent co-authors of Rifai include:

Julie E. Buring
Samia Mora
Paul M. Ridker
Nancy R. Cook
JoAnn E. Manson

Their research has been published predominantly in Clinical Chemistry, followed by the European Heart Journal, BMJ Open, Atherosclerosis, and the New England Journal of Medicine.

Best Publications

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

Paul M. Ridker;Nader Rifai;Lynda Rose;Julie E. Buring

10237
Citations
Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association

Thomas A. Pearson;George A. Mensah;R. Wayne Alexander;Jeffrey L. Anderson

9636
Citations
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Paul M Ridker;Charles H Hennekens;Julie E Buring;Nader Rifai

8458
Citations
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Aruna D. Pradhan;JoAnn E. Manson;Nader Rifai;Julie E. Buring

5914
Citations
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies

Patrick M Bossuyt;Johannes B Reitsma;David E Bruns;Constantine A Gatsonis

5718
Citations
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events An 8-Year Follow-Up of 14 719 Initially Healthy American Women

Paul M Ridker;Julie E. Buring;Nancy R. Cook;Nader Rifai

3336
Citations
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

Paul M. Ridker;Nader Rifai;Meir J. Stampfer;Charles H. Hennekens

3293
Citations
C-Reactive Protein Levels and Outcomes after Statin Therapy

Paul M Ridker;Christopher P. Cannon;David Morrow;Nader Rifai

2599
Citations
Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Nader Rifai;Michael A Gillette;Steven A Carr

2582
Citations
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score

Paul M Ridker;Julie E. Buring;Nader Rifai;Nancy R. Cook

2551
Citations
STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.

Patrick M. Bossuyt;Johannes B. Reitsma;David E. Bruns;Constantine A. Gatsonis

2407
Citations
Effect of Statin Therapy on C-Reactive Protein Levels: The Pravastatin Inflammation/CRP Evaluation (PRINCE): A Randomized Trial and Cohort Study

Michelle A. Albert;Ellie Danielson;Nader Rifai;Paul M Ridker

2403
Citations
Plasma adiponectin levels and risk of myocardial infarction in men

T Pischon;C.J Girman;G.S Hotamisligil;N Rifai

2392
Citations
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Paul M. Ridker;Nader Rifai;Michael Clearfield;John R. Downs

2272
Citations
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

Paul M. Ridker;Nader Rifai;Marc A. Pfeffer;Frank Sacks

2257
Citations
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.

Sandeep Bansal;Julie E. Buring;Nader Rifai;Samia Mora

2202
Citations
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

James F. Toole;M. René Malinow;Lloyd E. Chambless;J. David Spence

1968
Citations
Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease

P.M Ridker;M.J Stampfer;N Rifai

1921
Citations
Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

Paul M. Ridker;Nader Rifai;Marc A. Pfeffer;Frank M. Sacks

1823
Citations
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events☆

P.M Ridker;N Rifai;M Clearfield

1159
Citations

Frequent Co-Authors

Paul M. Ridker Brigham and Women's Hospital

Eric B. Rimm Harvard University

JoAnn E. Manson Harvard Medical School

Frank B. Hu Harvard University

Julie E. Buring Brigham and Women's Hospital

Elizabeth A. Platz Johns Hopkins University

David A. Morrow Brigham and Women's Hospital

Meir J. Stampfer Harvard University

Christopher P. Cannon Brigham and Women's Hospital

Eugene Braunwald Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of health-related degrees and career options. Many students choose alternative or complementary pathways online, making healthcare education more accessible and flexible.

A healthcare administration online degree prepares graduates for leadership roles in hospitals, clinics, or medical offices. For those aiming to become advanced practice nurses, asn to nurse practitioner programs provide a bridge from a registered nurse license to a master’s degree, opening advanced clinical or specialized nursing careers.

Students interested in nutrition and wellness may consider an online nutritionist degree to work in public health, private practice, or corporate wellness. Meanwhile, the top cahme-accredited mha programs equip future healthcare managers with essential skills for high-level administration in healthcare systems.

These related online degrees offer flexible options for students seeking to enter or advance in the healthcare industry, whether in clinical, administrative, or specialized roles.